Abigail H. Rizk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abigail H. Rizk has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Jennifer Berkowicz Lemoine
College of Nursing University of Utah Salt Lake City Utah
1 shared publicationLeissa Roberts
College of Nursing University of Utah Salt Lake City Utah
1 shared publication- Lisa Taylor-Swanson
College of Nursing, University of Utah, Salt Lake City, Utah, USA
1 shared publication Marcela Smid
Division of Maternal‐Fetal Medicine, School of Medicine University of Utah Salt Lake City Utah
1 shared publication- Sara Ellis Simonsen
College of Nursing, University of Utah, 10 South 2000 East, Salt Lake City, Utah, USA
1 shared publication
Latest Publications
- 12 August 2019
- Published by Wiley in Journal of Midwifery & Women's Health
- Vol. 64 (5) , 532-544
Maternity Care for Pregnant Women with Opioid Use Disorder: A Review
Opioid misuse is a problem that is complex and widespread. Opioid misuse rates are rising across all US demographics, including among pregnant women. The opioid epidemic brings a unique set of challenges for maternity health care providers, ranging from ethical considerations to the complex health needs and risks for both woman and fetus. This article addresses care for pregnant women during the antepartum, intrapartum, and postpartum periods through the lens of the opioid epidemic, including screening and counseling, an interprofessional approach to prenatal care, legal considerations, and considerations for care during labor and birth and postpartum. Providers can be trained to identify at‐risk women through the evidence‐based process of Screening, Brief Intervention, and Referral to Treatment (SBIRT) and connect them with the appropriate care to optimize outcomes. Women at moderate risk of opioid use disorder can be engaged in a brief conversation with their provider to discuss risks and enhance motivation for healthy behaviors. Women with risky opioid use can be given a warm referral to pharmacologic treatment programs, ideally comprehensive prenatal treatment programs where available (a warm referral is a term used when a provider, with the patient's permission, contacts another provider or another service him or herself rather than providing a phone number and referral number). Evidence regarding care for the pregnant woman with opioid use disorder and practical clinical recommendations are provided.
- 12 August 2019
- Published by Wiley in Journal of Midwifery & Women's Health
- Vol. 64 (5) , 532-544
Maternity Care for Pregnant Women with Opioid Use Disorder: A Review
Opioid misuse is a problem that is complex and widespread. Opioid misuse rates are rising across all US demographics, including among pregnant women. The opioid epidemic brings a unique set of challenges for maternity health care providers, ranging from ethical considerations to the complex health needs and risks for both woman and fetus. This article addresses care for pregnant women during the antepartum, intrapartum, and postpartum periods through the lens of the opioid epidemic, including screening and counseling, an interprofessional approach to prenatal care, legal considerations, and considerations for care during labor and birth and postpartum. Providers can be trained to identify at‐risk women through the evidence‐based process of Screening, Brief Intervention, and Referral to Treatment (SBIRT) and connect them with the appropriate care to optimize outcomes. Women at moderate risk of opioid use disorder can be engaged in a brief conversation with their provider to discuss risks and enhance motivation for healthy behaviors. Women with risky opioid use can be given a warm referral to pharmacologic treatment programs, ideally comprehensive prenatal treatment programs where available (a warm referral is a term used when a provider, with the patient's permission, contacts another provider or another service him or herself rather than providing a phone number and referral number). Evidence regarding care for the pregnant woman with opioid use disorder and practical clinical recommendations are provided.